289 related articles for article (PubMed ID: 23725275)
1. Cytotoxic T lymphocytes: the future of cancer stem cell eradication?
Saijo H; Hirohashi Y; Torigoe T; Kochin V; Takahashi H; Sato N
Immunotherapy; 2013 Jun; 5(6):549-51. PubMed ID: 23725275
[No Abstract] [Full Text] [Related]
2. [Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy].
Miyamoto S; Kanaseki T; Hirohashi Y; Tsukahara T; Kikuchi Y; Sato N; Torigoe T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):40-47. PubMed ID: 28539553
[TBL] [Abstract][Full Text] [Related]
3. [New era of tumor immunotherapy].
Yoshitake Y; Nakatsura T; Nishimura Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
[No Abstract] [Full Text] [Related]
4. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
Shurin MR; Gregory M; Morris JC; Malyguine AM
Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
[TBL] [Abstract][Full Text] [Related]
5. [Peptide-based vaccine therapy for cancer patients].
Yamada A
Nihon Rinsho; 2005 Apr; 63 Suppl 4():602-7. PubMed ID: 15861717
[No Abstract] [Full Text] [Related]
6. Cancer immunotherapy with MAGE antigens.
Coulie PG
Suppl Tumori; 2002; 1(4):S63-5. PubMed ID: 12415826
[No Abstract] [Full Text] [Related]
7. How much help does a vaccine-induced T-cell response need?
Weber JS; Mulé JJ
J Clin Invest; 2001 Mar; 107(5):553-4. PubMed ID: 11238555
[No Abstract] [Full Text] [Related]
8. [Cancer treatment by comprehensive regulation of anti-tumor immune network].
Kawakami Y
Nihon Rinsho; 2010 Jun; 68(6):1094-9. PubMed ID: 20535961
[TBL] [Abstract][Full Text] [Related]
9. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
Nelson B
Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
[No Abstract] [Full Text] [Related]
10. Human tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines?
Coulie PG
Mol Med Today; 1997 Jun; 3(6):261-8. PubMed ID: 9211417
[TBL] [Abstract][Full Text] [Related]
11. Tumor resistance to CD8+ T cell-based therapeutic vaccination.
Huang Y; Shah S; Qiao L
Arch Immunol Ther Exp (Warsz); 2007; 55(4):205-17. PubMed ID: 17659376
[TBL] [Abstract][Full Text] [Related]
12. DC-based cancer vaccines: lessons from clinical trials.
Brody JD; Engleman EG
Cytotherapy; 2004; 6(2):122-7. PubMed ID: 15203988
[No Abstract] [Full Text] [Related]
13. WT1 peptide vaccine, one of the most promising cancer vaccines: its present status and the future prospects.
Oka Y; Sugiyama H
Immunotherapy; 2010 Sep; 2(5):591-4. PubMed ID: 20874639
[No Abstract] [Full Text] [Related]
14. Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.
Bendle GM; Holler A; Downs AM; Xue SA; Stauss HJ
Expert Opin Biol Ther; 2005 Sep; 5(9):1183-92. PubMed ID: 16120049
[TBL] [Abstract][Full Text] [Related]
15. [Cancer immunotherapy: new approaches].
Blay JY; Thomachot MC; Alberti L; Bachelot T; Voorzanger-Rousselot N; Puisieux I; Odin L; Ménétrier-Caux C
Bull Cancer; 2000 Jan; 87(1):97-106. PubMed ID: 10673638
[No Abstract] [Full Text] [Related]
16. Immunologic Targeting of Cancer Stem Cells.
Zhang J; Li Q; Chang AE
Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor immunity and cellular cancer therapies].
Catros-Quemener V; Bouet F; Genetet N
Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?
Dillman RO; Cornforth AN; Nistor G
Expert Opin Biol Ther; 2013 May; 13(5):643-56. PubMed ID: 23451922
[TBL] [Abstract][Full Text] [Related]
19. Generation of dendritic cell-based vaccines for cancer therapy.
Reinhard G; Märten A; Kiske SM; Feil F; Bieber T; Schmidt-Wolf IG
Br J Cancer; 2002 May; 86(10):1529-33. PubMed ID: 12085199
[TBL] [Abstract][Full Text] [Related]
20. Circumvention of tumor cell escape following specific immunotherapy.
Frost P; Bonavida B
Cancer Biother Radiopharm; 2000 Apr; 15(2):141-52. PubMed ID: 10803319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
